Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
Guest Alerts | Access Rights | My Account | Sign In
|
|
Sci. STKE, 28 October 2003 PERSPECTIVESTherapeutic Potential of Antisense Nucleic Acid MoleculesJoanna B. Opalinska1* and Alan M. Gewirtz2*
1Department of Hematology, Pommeranian Medical Academy, ul. Unii Lubelskiej 1, 71245 Szczecin, Poland. Summary: Elucidation of many disease-related signal transduction and gene expression pathways has provided unparalleled opportunities for the development of targeted therapeutics. The types of molecules in development are increasingly varied and include small-molecule enzyme inhibitors, humanized antibodies to cell surface receptors, and antisense nucleic acids for silencing the expression of specific genes. This Perspective reviews the basis for various antisense strategies for modulating gene expression, including RNA interference, and discusses the prospects for their clinical use. *Corresponding authors. E-mail: jopal{at}poczta.onet.pl(J.B.O.); gewirtz{at}mail.med.upenn.edu(A.M.G.)
Citation: J. B. Opalinska, A. M. Gewirtz, Therapeutic Potential of Antisense Nucleic Acid Molecules. Sci. STKE 2003, pe47 (2003). The editors suggest the following Related Resources on Science sites:In Science Signaling
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
|
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882